According to Aarti Drugs's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.73128. At the end of 2023 the company had a P/S ratio of 1.69.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.69 | 9.54% |
2022 | 1.54 | -29.63% |
2021 | 2.19 | -31.33% |
2020 | 3.18 | 336.21% |
2019 | 0.7299 | -21.83% |
2018 | 0.9337 | -26.43% |
2017 | 1.27 | 6.1% |
2016 | 1.20 | -5.18% |
2015 | 1.26 | 37.66% |
2014 | 0.9164 | 217.49% |
2013 | 0.2887 |